The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $47,610.00 firm fixed price purchase order to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for an annual maintenance agreement to support the NIAID's Illumina NextSeq 2000 genetic sequencing system in Cambodia. This award is not associated with a larger contract vehicle. No set-aside designations were used. Bio-Active Company LIMITED has previously provided genetic sequencing systems, reagents, and testing materials to support infectious disease monitoring and research for various U.S. government health organizations operating in Thailand.
Generated 3/5/25, 10:03 AM